Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-01

Clinical Trial Update: Study of Cabazitaxel in Patients With Metastatic Breast Cancer Previously Treated With Taxanes [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating cabazitaxel in metastatic breast cancer patients previously treated with taxanes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Jevtana (cabazitaxel)

Snippet

Sponsor: Hellenic Cooperative Oncology Group | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED